Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noffar Bar

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 10, 2019
The impact of a multimodal approach to vancomycin discontinuation in hematopoietic stem cell transplant recipients (HSCT) with febrile neutropenia (FN)Sarah Perreault, Dayna McManus, Noffar Bar, et al.
Blood Advances|January 4, 2018
Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapyJithendra Kini Bailur, Sameet Mehta, Lin Zhang, et al.
American Journal of Hematology|June 17, 2026
Cumulative Antigen Suppression Reduces Clonal Plasma Cell Evolution in Gaucher DiseaseNoor Ul Ain, Noffar Bar, Lilu Guo, et al.
Advances in Therapy|February 2, 2026
Ciltacabtagene Autoleucel Versus Idecabtagene Vicleucel in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma with 2-4 Prior Lines of Therapy: Updated Matching-Adjusted Indirect ComparisonNieves Lopez-Muñoz, Noffar Bar, Joris Diels, et al.
The Journal of Clinical Investigation|January 9, 2018
Early B cell changes predict autoimmunity following combination immune checkpoint blockadeRituparna Das, Noffar Bar, Michelle Ferreira, et al.
Current Medical Research and Opinion|August 12, 2024
Comparative efficacy of ciltacabtagene autoleucel versus idecabtagene vicleucel in the treatment of patients with relapsed or refractory multiple myeloma previously treated with 2-4 prior lines of therapy: a matching-adjusted indirect comparisonNoffar Bar, Joris Diels, Suzy van Sanden, et al.
JCI Insight|December 27, 2016
Interlesional diversity of T cell receptors in melanoma with immune checkpoints enriched in tissue-resident memory T cellsChandra Sekhar Boddupalli, Noffar Bar, Krishna Kadaveru, et al.
European Journal of Haematology|July 24, 2022
Association of iron infusion reactions with ABO blood typeAyesha Butt, Tinatin Muradashvili, Sara Soliman, et al.
JCI Insight|April 24, 2019
Early alterations in stem-like/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathyJithendra Kini Bailur, Samuel S McCachren, Deon B Doxie, et al.
JCI Insight|May 20, 2020
Differential effects of PD-L1 versus PD-1 blockade on myeloid inflammation in human cancerNoffar Bar, Federica Costa, Rituparna Das, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 10, 2019
The impact of a multimodal approach to vancomycin discontinuation in hematopoietic stem cell transplant recipients (HSCT) with febrile neutropenia (FN)Sarah Perreault, Dayna McManus, Noffar Bar, et al.
Blood Advances|January 4, 2018
Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapyJithendra Kini Bailur, Sameet Mehta, Lin Zhang, et al.
American Journal of Hematology|June 17, 2026
Cumulative Antigen Suppression Reduces Clonal Plasma Cell Evolution in Gaucher DiseaseNoor Ul Ain, Noffar Bar, Lilu Guo, et al.
Advances in Therapy|February 2, 2026
Ciltacabtagene Autoleucel Versus Idecabtagene Vicleucel in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma with 2-4 Prior Lines of Therapy: Updated Matching-Adjusted Indirect ComparisonNieves Lopez-Muñoz, Noffar Bar, Joris Diels, et al.
The Journal of Clinical Investigation|January 9, 2018
Early B cell changes predict autoimmunity following combination immune checkpoint blockadeRituparna Das, Noffar Bar, Michelle Ferreira, et al.
Current Medical Research and Opinion|August 12, 2024
Comparative efficacy of ciltacabtagene autoleucel versus idecabtagene vicleucel in the treatment of patients with relapsed or refractory multiple myeloma previously treated with 2-4 prior lines of therapy: a matching-adjusted indirect comparisonNoffar Bar, Joris Diels, Suzy van Sanden, et al.
JCI Insight|December 27, 2016
Interlesional diversity of T cell receptors in melanoma with immune checkpoints enriched in tissue-resident memory T cellsChandra Sekhar Boddupalli, Noffar Bar, Krishna Kadaveru, et al.
European Journal of Haematology|July 24, 2022
Association of iron infusion reactions with ABO blood typeAyesha Butt, Tinatin Muradashvili, Sara Soliman, et al.
JCI Insight|April 24, 2019
Early alterations in stem-like/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathyJithendra Kini Bailur, Samuel S McCachren, Deon B Doxie, et al.
JCI Insight|May 20, 2020
Differential effects of PD-L1 versus PD-1 blockade on myeloid inflammation in human cancerNoffar Bar, Federica Costa, Rituparna Das, et al.
Pageof 3